Background
Methods
Study protocol
Search strategy
Language
Data management and selection process
Study eligibility criteria
Study selection and inclusion
Participants
Interventions
Comparator
Outcomes
Timing
Exclusion criterion
Data extraction
Data items
Quality assessment
Data synthesis
Results
Study selection
Study characteristics
Study types and designs
Year of publication
Sample size
Settings and country of origin
DMPA service providers
DMPA recipients
Interventions
Outcomes and outcome measures
Descriptive studies
Non-randomized community trials (non-RCTs)
Quality assessment and risk of bias in studies
Reference, country | Overall quality assessments | Components of quality assessment | |||||
---|---|---|---|---|---|---|---|
Selection biasa | Study Design | Confoundingb | Blinding | Data collection methodc | Withdrawals and drop-outs | ||
Weidert et al. [10] Ethiopia | Moderate | Strong | Strong | Weak | Weak | Moderate | NA |
Okegbe et al. [4] Republic of Benin | Moderate | Strong | Strong | Weak | Weak | Moderate | NA |
Mwembo et al. [14] Democratic Republic of Congo | Moderate | Moderate | Strong | Weak | Weak | Moderate | Moderate |
Comfort et al. [17] Madagascar | Weak | Weak | Moderate | Weak | Weak | Moderate | NA |
Prata et al. [21] Ethiopia | Weak | Weak | Strong | Weak | Weak | Moderate | Moderate |
Stanback et al. [19] Uganda | Weak | Weak | Strong | Strong | Weak | Moderate | Strong |
Krueger et al. [25] Uganda | Weak | Weak | Moderate | Weak | Weak | Strong | NA |
Hoke et al. [18] Madagascar | Weak | Strong | Moderate | Weak | Weak | Moderate | NA |
Jacinto et al. [22] Mozambique | Weak | Strong | Strong | Weak | Weak | Moderate | Strong |
Chin-quee et al. [15] Zambia | Weak | Strong | Moderate | Weak | Weak | Moderate | NA |
Olawo et al. [23] Kenya | Weak | Weak | Moderate | Weak | Weak | Strong | Strong |
FHI-USAID [24] Senegal | Weak | Strong | Moderate | Weak | Weak | Strong | Strong |
Poss et al. [20] Uganda | Weak | Weak | Moderate | Strong | Weak | Moderate | Weak |
Safety
Uptake of DMPA services
DMPA uptake | |||||||
---|---|---|---|---|---|---|---|
Author, country | Mode of outcome measurement | Provider | Number of clients | New to family planning | New to DMPA | Returning users | Desire to switch provider |
Weidert et al. [10] Ethiopia | CHW reports | CHW | 8604 | 19% | 25% | NR | NR |
Okegbe et al. [4] Republic of Benin | CHW reports | CHW | 35,000 | 80% | 22.8% | NR | 54% |
Mwembo et al. [14] Democratic Republic of Congo | CHW reports | CHW | 252 | 70% | 69.8% | NR | NR |
Comfort et al. [17] Madagascar | CHW reports | CHW | 622 | NA | NA | NA | NA |
Chin-quee et al. [15] Zambia | Client interview | CHW | 3479 | 42.5% | 24% | NR | 20% |
Hoke et al. [18] Madagascar | CHW reports | CHW | 303 | 28% | 25% | 50% | NR |
Olawo et al. [23] Kenya | CHW reports | CHW | 832 | 14% | 12% | NR | 74% |
FHI-USAID [24] Senegal | CHW reports | CHW | 308 | 64% | 15% | NR | 21%*** |
Krueger et al. [25] Uganda | Client registers | CHW CLINIC | 1364 457 | NR NR | 30% 57% | NR NR | NR NR |
Prata et al. [21] Ethiopia | Client surveys at enrolment, 13th week and 6 months | CHW CLINIC | 622 440 | NR NR | 58.4%** 45.9% | 34% 44% | 0 52% |
Stanback et al. [19] Uganda | Client surveys at enrolment, 13th week | CHW CLINIC | 449 328 | NR NR | 86% 76% | NR NR | NR NR |
Poss et al. [20] Uganda | Client surveys at 3rd year | CHW CLINIC | 308 217 | NR NR | NR NR | NR NR | 38.9% 41.5% |
Jacinto et al. [22] Mozambique | Client surveys at enrolment, 13th week and 6 months | CHW (TBA) CHW (APE) | 782 649 | 63% 66% | NR NR | 30% | NR NR |
Safety | |||
---|---|---|---|
Author, country | Mode of outcome measurement | Provider | Injection site morbidity |
Weidert et al. [10] Ethiopia | CHW reports | CHW | NR |
Okegbe et al. [4] Republic of Benin | CHW reports | CHW | NR |
Mwembo et al. [14] Democratic Republic of Congo | CHW reports | CHW | 40.6% |
Comfort et al. [17] Madagascar | CHW reports | CHW | NA |
Chin-quee et al. [15] Zambia | Client interview | CHW | 2% |
Hoke et al. [18] Madagascar | CHW reports | CHW | 3% |
Olawo et al. [23] Kenya | CHW reports | CHW | 0 |
FHI-USAID [24] Senegal | CHW reports | CHW | NR |
Krueger et al. [25] Uganda | Client registers | CHW CLINIC | 0 0 |
Prata et al. [21] Ethiopia | Client surveys at enrolment, 13th week and 6 months | CHW CLINIC | 2.1% 0.5% |
Stanback et al. [19] Uganda | Client surveys at enrolment, 13th week | CHW CLINIC | 0.7% 0.3% |
Poss et al. [20] Uganda | Client surveys at 3rd year | CHW CLINIC | NA NA |
Jacinto et al. [22] Mozambique | Client surveys at enrolment, 13th week and 6 months | CHW (TBA) CHW (APE) | < 0.5% |
Continuation rates
Continuation rates | ||||||
---|---|---|---|---|---|---|
Author, country | Mode of outcome measurement | Provider | Number of women, 1st injection | 3 months | 6 months | 9 months |
Weidert et al. [10] Ethiopia | CHW reports | CHW | 8604 | NR | NR | NR |
Okegbe et al. [4] Republic of Benin | CHW reports | CHW | 7997 | NR | NR | NR |
Mwembo et al. [14] Democratic Republic of Congo | CHW reports | CHW | 252 | 94.8% | 92.1% | NR |
Comfort et al. [17] Madagascar | CHW reports | CHW | NR | NA | NA | NA |
Chin-quee et al. [15] Zambia | Client interview | CHW | 253 | 94% | NR | NR |
Hoke et al. [18] Madagascar | CHW reports | CHW | 303 | 96% | NR | NA |
Olawo et al. [23] Kenya | CHW reports | CHW | 832 | 89% | 81% | 68% |
FHI-USAID [24] Senegal | CHW reports | CHW | 308 | 93% | NR | NR |
Krueger et al. [25] Uganda | Client registers | CHW CLINIC | NR NR | 72% NA | 70% 57% | 84% NA |
Prata et al. [21] Ethiopia | Client surveys at enrolment, 13th week and 6 months | CHW CLINIC | 622 440 | 83.7%** 81.6% | 78.8%** 62.3% | NR NR |
Stanback et al. [19] Uganda | Client surveys at enrolment, 13th week | CHW CLINIC | 449 328 | 88% 85% | NR NR | NR NR |
Jacinto et al. [22] Mozambique | Client surveys at enrolment, 13th week and 6 months | CHW (TBA) CHW (APE) | 782 649 | 80% 68.1% | 91.6% 68.6% | NR NR |
Client satisfaction
Satisfaction | |||||
---|---|---|---|---|---|
Author, country | Mode of outcome measurement | Provider | Number of clients | With DMPA | With provider |
Weidert et al. [10] Ethiopia | CHW reports | CHW | 8604 | 47.8% | 39.4% |
okegbe et al. [4] Republic of Benin | CHW reports | CHW | 35,000 | 22.8% | NR |
Mwembo et al. [14] Democratic Republic of Congo | CHW reports | CHW | 252 | 96.1% | 87% |
Comfort et al. [17] Madagascar | CHW reports | CHW | 622 | NA | NA |
Chin-Quee et al. [15] Zambia | Client interview | CHW | 253 | 94% | NR |
Hoke et al. [18] Madagascar | CHW reports | CHW | 303 | 96% | NR |
Olawo et al. [23] Kenya | CHW reports | CHW | 832 | NR | 81% |
Fhi-Usaid [24] Senegal | CHW reports | CHW | 308 | NR | NR |
Prata et al. [21] Ethiopia | Client surveys at enrolment, 13th week and 6 months | CHW CLINIC | 622 440 | 99.2% (98.8%)* 98.4% (100%)* | 95.6% (96.2%)* 97.6% (97.6%)* |
Stanback et al. [19] Uganda | Client surveys at enrolment, 13th week | CHW CLINIC | 449 328 | 93% 90% | 95% 93% |
Jacinto et al. [22] Mozambique | Client surveys at enrolment, 13th week and 6 months | CHW (TBA) CHW (APE) | 782 649 | 74.7% (90.1%)* 88.2% (89.2%)* | 73.7% (89.8%)* 89.1% (94.1%)* |